COL4a5 Antikörper (N-Term)
-
- Target Alle COL4a5 (COL4A5) Antikörper anzeigen
- COL4a5 (COL4A5) (Collagen, Type IV, alpha 5 (COL4A5))
-
Bindungsspezifität
- AA 40-120, N-Term
- Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser COL4a5 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Rabbit polyclonal to COL4A5.
- Spezifität
- COL4A5 Polyclonal Antibody detects endogenous levels of COL4A5 protein.
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from human COL4A5
- Isotyp
- IgG
- Top Product
- Discover our top product COL4A5 Primärantikörper
-
-
- Applikationshinweise
-
IHC 1:100-1:300
IF 1:200-1:1000
ELISA 1:10000 - Kommentare
-
Isoform 2 is found in kidney.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C, and avoid repeat freeze-thaw cycles.
-
- Target
- COL4a5 (COL4A5) (Collagen, Type IV, alpha 5 (COL4A5))
- Andere Bezeichnung
- COL4A5 (COL4A5 Produkte)
- Synonyme
- ASLN antikoerper, ATS antikoerper, CA54 antikoerper, RGD1565499 antikoerper, col4a5 antikoerper, fj65e07 antikoerper, im:7157877 antikoerper, si:ch211-174g17.1 antikoerper, wu:fj65e07 antikoerper, collagen type IV alpha 5 chain antikoerper, collagen, type IV, alpha 5 antikoerper, collagen, type IV, alpha 1 antikoerper, COL4A5 antikoerper, Col4a5 antikoerper, col4a1 antikoerper, LOC100285389 antikoerper
- Molekulargewicht
- 160 kDa
- Gen-ID
- 1287
- UniProt
- P29400
- Pathways
- Skeletal Muscle Fiber Development
-